Eli Lilly Weight Loss Pill - Search News

Eli Lilly, Novo Nordisk

Seeking Alpha on MSN · 2d

How does Viking's weight loss med compare to ones from Novo, Eli Lilly?

Data reported earlier Monday from Viking Therapeutics (NASDAQ:VKTX) on its weight loss medicine VK2735 indicates that Novo Nordisk (NVO) and Eli Lilly (NYSE:LLY), which currently dominate the obesity drug space,

Barron's on MSN · 3d

This Pharma Stock Is Rising. The Weight-Loss Drugs Race Has Widened Beyond Lilly, Novo.

Viking says an early-stage study of its obesity pill VK2735 showed adults on the highest dosage lost 8.2% of their body weight in four weeks.

Eli Lilly's Zepbound sales, Pfizer wants in on weight loss drugs, AbbVie's big deal: Pharma news round up

Eli Lilly CEO David Ricks told investors this week that the sale of cheaper, knockoff versions of the company’s blockbuster weight loss drug Zepbound was not dragging down sales. Pfizer sales rose 31% to $17.

3d

Americans seeking Eli Lilly and Novo Nordisk’s weight-loss drugs turn to compounded market

Analysts have struggled to estimate the size of the compounded market for weight-loss drugs because their sale is not ...

3d

Wall Street Lunch: Viking Weight-Loss Pill Data Is Striking

VK2735 is a dual GLP-1/GIP receptor agonist similar to Eli Lilly's (LLY) blockbuster weight loss drug Zepbound, ...

Viking Touts Promising Phase I Weight Loss Data for Obesity Pill Candidate

Jefferies analyst Roger Song in an investor note said that Viking Therapeutics’ readout for its investigational therapy ...

8don MSN

Jim Cramer on Eli Lilly and Company (LLY): ‘One Of Our Best Picks For The Charitable Trust’

This is what he said in the most recent episode: “Now Wednesday morning, Eli Lilly, one of our best picks for the ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results